Lam Research Corp (LRCX) Tops Q4 EPS by 5c, Stock Halted
Tweet
Share
E-mailGet Alerts LRCX Hot Sheet
Price: $327.71 -2.76%
Financial Fact:
Selling, general and administrative: 165.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, general and administrative: 165.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Lam Research Corp (NASDAQ: LRCX) reported Q4 EPS of $1.14, $0.05 better than the analyst estimate of $1.09. Revenue for the quarter came in at $752 million versus the consensus estimate of $748.75 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lam Research plans $3B R&D expansion over five years
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
